INNOVATION PHARMACEUTICALS INC. Finite-Lived Intangible Assets, Gross
INNOVATION PHARMACEUTICALS INC. had Finite-Lived Intangible Assets, Gross of $5.55 million as of 2021-12-31, per its 10-Q filed 2022-02-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Finite-Lived, after Accumulated Amortization › Intangible Asset, Finite-Lived, before Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsGross · last filed 2022-02-14
- 2021-12-31: Finite-Lived Intangible Assets, Gross $5.55M.
- 2021-09-30: Finite-Lived Intangible Assets, Gross $5.52M.
- 2021-06-30: Finite-Lived Intangible Assets, Gross $5.51M.
- 2021-03-31: Finite-Lived Intangible Assets, Gross $5.49M.
| Period end | Finite-Lived Intangible Assets, Gross |
|---|---|
| 2021-12-31 | $5.55M 10-Q · filed 2022-02-14 |
| 2021-09-30 | $5.52M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $5.51M 10-Q · filed 2022-02-14 |
| 2021-03-31 | $5.49M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $5.48M 10-Q · filed 2021-02-22 |
| 2020-06-30 | $5.43M 10-K · filed 2021-09-27 |